D-Wave Quantum: A Korean Memorandum, a Japanese Prize and the Revenue Question Neither Answers
Published on 10/29/2026 at 12:31 | Editorial boerse-global.de
D-Wave Quantum shares slipped 4.3% in the prior session, caught in a sector-wide selloff across quantum computing names. Media reports pointed to profit-taking after an earlier rebound and caution ahead of the Federal Reserve's rate decision as the sector-wide drags. On the company's own ledger, a customer research award and a freshly filed securities class action sit side by side — and neither speaks directly to the issue that matters most to investors: whether demand can be converted into booked revenue on schedule.
Two Levels of News, One Underlying Test
The company said its customer Shionogi took first place in the quality-of-life category at Japan's NEDO Quantum Computing Challenge. The ¥40 million prize is earmarked to fund further research into quantum-assisted drug discovery, and the winning work included a peer-reviewed study using D-Wave's annealing technology. It is a genuine endorsement of the technology's application — but it answers a scientific question, not a commercial one.
The legal front runs on a separate track. Portnoy Law announced that a securities class action has been filed on behalf of buyers of D-Wave stock between February 26 and August 25, 2026. The suit alleges misleading statements about order intake, commercial usage and delayed system deliveries. These are accusations, not established facts, and the firm's notice offers no basis for judging their merit. Nor does the filing by itself explain the previous day's share-price decline.
What the Complaints Actually Target
The allegations converge on a single theme: the gap between announced demand and realized revenue. Pomerantz, which has also published on the case, notes the claim that record bookings consisted mainly of two contracts signed before the proposed class period — and therefore demonstrated no new or expanded commercial adoption. Rosen Law Firm highlights the same point. Another alleged misstep concerns how D-Wave characterized installation timelines and its ability to turn demand into system sales.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The numbers give those claims a factual backdrop. According to the Pomerantz release, D-Wave posted revenue of $2.86 million in the first quarter of 2026 against an analyst expectation of $4.04 million. In the second quarter, revenue came in at $3.08 million, down from $3.1 million a year earlier, again missing the consensus figure cited in the notice. Management has attributed revenue fluctuations to the timing of installations and to progress recognition under the percentage-of-completion method.
The FAU Contract as a Live Gauge
The most concrete yardstick is the purchase agreement closed on January 27 with FAU for a quantum system valued at $20 million, with delivery originally expected later in the current year. Per Pomerantz's account, installation of that system was supposed to begin before year-end. A start to installation, however, would not equal full recognition of the contract's value — a distinction that goes to the heart of the dispute.
Investors would therefore find progress disclosures especially useful if they tied installation milestones directly to revenue recognition. That is the link the litigation puts under a microscope, and it is the one a new partnership cannot address on its own.
Korea Adds a Door, Not a Receipt
The memorandum of understanding signed with LG CNS opens another avenue. The two companies aim to advance quantum-computing-based optimization for enterprises in Korea and worldwide, moving beyond proof-of-concept work into real industrial applications by combining D-Wave's annealing approach with LG CNS's optimization and integration expertise. The document is legally non-binding and provides no evidence of additional revenue.
That leaves shareholders weighing two distinct questions. The collaboration could widen access to industrial use cases. A firmer read on the business, though, requires signed deals and their execution. LG CNS could help develop applications and embed them in corporate processes — the partners explicitly intend to go past feasibility studies — but that remains a possibility rather than a confirmed commercial success. For the optimistic case to hold, D-Wave would not need immediate large proceeds from the Korean tie-up; it would need existing projects to advance in a verifiable way, with bookings, installation progress and the resulting revenue traceable as a chain.
D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.
The Calendar Ahead
The pessimistic case is another gap between stated potential and realized proceeds. Further slips in system deliveries and the associated revenue would sharpen that risk. The next hard operational checkpoint is the announced start of the FAU installation before the end of 2026.
A legal deadline runs in parallel: investors may seek appointment as lead plaintiff by December 15, as the involved firms note. No class has yet been certified, and the date governs procedure rather than the validity of the allegations.
D-Wave reports third-quarter 2026 results before the market opens on November 10, with a webcast scheduled for 8:00 a.m. Eastern Time. That release is the next scheduled occasion to judge the business on published figures. The research prize honors scientific work; the lawsuit targets statements about commercial development. What ultimately settles the stock's direction is not the count of favorable technology headlines but how those headlines stack up against reported results — and whether installations finally turn into revenue.
Ad
D-Wave Quantum Stock: New Analysis - 29 October
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
